Subtopic Deep Dive
C-Reactive Protein in Cancer-Related Inflammation
Research Guide
What is C-Reactive Protein in Cancer-Related Inflammation?
C-Reactive Protein (CRP) serves as an acute-phase inflammatory biomarker elevated in cancer-related inflammation, linking tumor progression, genetic instability, and therapeutic resistance to poor prognosis.
CRP levels rise at cancer inflammation sites, correlating with disease advancement (McMillan, 2008; 470 citations). Studies show CRP integrates into inflammation-based prognostic scores for cancer nutrition management (McMillan, 2008). Over 10 papers from 2008-2021 explore CRP alongside ratios like NLR and PLR in solid tumors.
Why It Matters
CRP monitoring predicts cancer survival and guides nutrition-based interventions, as pretreatment serum albumin inversely relates to outcomes (Gupta and Lis, 2010; 1436 citations). Elevated CRP in tumor microenvironments with macrophages and neutrophils signals progression (Kim and Bae, 2016; 828 citations). In pancreatic and colorectal cancers, high neutrophil-lymphocyte ratios tied to CRP indicate chemotherapy resistance and reduced survival (Stotz et al., 2013; 490 citations; Chua et al., 2011; 470 citations).
Key Research Challenges
Heterogeneity in CRP Assays
Variations in CRP measurement methods across studies hinder meta-analyses. Templeton et al. (2014; 691 citations) noted inconsistencies in inflammation markers like PLR affecting prognostic reliability. Standardization remains unresolved in cancer cohorts.
Distinguishing Cancer from Comorbid Inflammation
CRP elevation confounds cancer prognosis with non-cancer inflammation like CKD (Mihai et al., 2018; 624 citations). McMillan (2008) highlighted CRP's role in systemic scores but lacks tumor-specific isolation. Multi-marker panels are underexplored.
Longitudinal Prognostic Validation
Short-term CRP changes lack validation against survival in diverse cancers. Stotz et al. (2013) showed NLR utility in pancreatic cancer but called for CRP-specific longitudinal data. Cupp et al. (2020; 646 citations) umbrella review urges prospective trials.
Essential Papers
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Digant Gupta, C. G. Lis · 2010 · Nutrition Journal · 1.4K citations
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim, Jong‐Sup Bae · 2016 · Mediators of Inflammation · 828 citations
Distinct tumor microenvironment forms in each progression step of cancer and has diverse capacities to induce both adverse and beneficial consequences for tumorigenesis. It is now known that immune...
Neutrophil-to-lymphocyte ratio, past, present and future perspectives
Roman Záhorec · 2021 · Bratislavské lekárske listy/Bratislava medical journal · 801 citations
In the review we analyzed short history of the establishment of a novel hematological parameter for systemic inflammation and stress coined as a neutrophil to lymphocyte ratio (NLR). Today NLR is w...
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton, Olga Ace, Mairéad G. McNamara et al. · 2014 · Cancer Epidemiology Biomarkers & Prevention · 691 citations
Abstract Background: Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor prognosis in sever...
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp, Margarita Cariolou, Ioanna Tzoulaki et al. · 2020 · BMC Medicine · 646 citations
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Simona Mihai, Elena Codrici, Ionela Daniela Popescu et al. · 2018 · Journal of Immunology Research · 624 citations
Persistent, low-grade inflammation is now considered a hallmark feature of chronic kidney disease (CKD), being involved in the development of all-cause mortality of these patients. Although substan...
Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions
Aleksandra Korniluk, Olga Martyna Koper‐Lenkiewicz, Joanna Kamińska et al. · 2019 · Mediators of Inflammation · 524 citations
Platelet size has been demonstrated to reflect platelet activity and seems to be a useful predictive and prognostic biomarker of cardiovascular events. It is associated with a variety of prothrombo...
Reading Guide
Foundational Papers
Start with McMillan (2008; 470 citations) for inflammation-based prognostic scores in cancer nutrition, then Gupta and Lis (2010; 1436 citations) for serum markers predicting survival.
Recent Advances
Study Záhorec (2021; 801 citations) on NLR evolution and Cupp et al. (2020; 646 citations) umbrella review for meta-evidence on inflammation ratios.
Core Methods
Core techniques include systemic inflammation indices (NLR, PLR), meta-analyses of hazard ratios (Templeton et al., 2014), and longitudinal cohort scoring (Stotz et al., 2013).
How PapersFlow Helps You Research C-Reactive Protein in Cancer-Related Inflammation
Discover & Search
Research Agent uses searchPapers('C-Reactive Protein cancer inflammation prognosis') to retrieve McMillan (2008; 470 citations), then citationGraph to map 50+ connected papers on inflammation scores, and findSimilarPapers for NLR/PLR analogs like Templeton et al. (2014). exaSearch uncovers hidden reviews on CRP in tumor microenvironments.
Analyze & Verify
Analysis Agent applies readPaperContent on Gupta and Lis (2010) to extract survival meta-data, verifyResponse with CoVe to cross-check CRP claims against 10 papers, and runPythonAnalysis for meta-regression on citation-provided hazard ratios using pandas. GRADE grading scores McMillan (2008) evidence as moderate for prognostic utility.
Synthesize & Write
Synthesis Agent detects gaps in CRP-specific trials versus NLR dominance (Cupp et al., 2020), flags contradictions in PLR thresholds (Templeton et al., 2014), and uses latexEditText with latexSyncCitations for prognostic score manuscripts. Writing Agent employs latexCompile and exportMermaid to diagram CRP-inflammation pathways.
Use Cases
"Run meta-analysis on CRP and NLR correlations in solid tumor survival data from these papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-regression on hazard ratios from Stotz et al. 2013, Chua et al. 2011) → researcher gets CSV of pooled ORs with p-values.
"Draft LaTeX review section on CRP prognostic scores citing McMillan 2008 and Gupta 2010."
Synthesis Agent → gap detection → Writing Agent → latexEditText → latexSyncCitations → latexCompile → researcher gets compiled PDF with inline citations and figure.
"Find GitHub repos analyzing CRP datasets from inflammation biomarker papers."
Research Agent → paperExtractUrls (McMillan 2008) → paperFindGithubRepo → githubRepoInspect → researcher gets code for CRP survival models with dataset links.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(CRP cancer) → citationGraph → DeepScan 7-steps analyzes 50+ papers like Kim and Bae (2016) with GRADE checkpoints. Theorizer generates hypotheses on CRP-NLR interactions from McMillan (2008) and Templeton (2014), outputting mermaid diagrams of mechanisms.
Frequently Asked Questions
What defines CRP's role in cancer inflammation?
CRP is an acute-phase protein elevated in cancer microenvironments, contributing to prognostic scores (McMillan, 2008).
What methods assess CRP prognostically?
Inflammation-based scores combine CRP with albumin and ratios like NLR/PLR (Gupta and Lis, 2010; Templeton et al., 2014).
What are key papers on CRP in cancer?
McMillan (2008; 470 citations) on prognostic scores; Gupta and Lis (2010; 1436 citations) on albumin-CRP survival links.
What open problems exist in CRP research?
Standardizing assays, isolating tumor-specific CRP, and validating longitudinal changes lack large trials (Cupp et al., 2020).
Research Inflammatory Biomarkers in Disease Prognosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching C-Reactive Protein in Cancer-Related Inflammation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers